MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2017 International Congress

    Objective measurement of upper extremity bradykinesia using the keyboard-based dexterity test

    S.-k. Song, J.-H. Kang (Jejusi, Republic of Korea)

    Objective: To objectively assess the bradykinesia of upper extremity using the Objective Movement Disorder Measurement (OMDM)-Dexterity test Background: Bradykinesia is one of the clinical hallmarks…
  • 2017 International Congress

    Do motor symptoms influence on malnutrition in Parkinson`s disease patients?

    S. Tomic, V. Pekic, Z. Popijac, T. Pucic, M. Petek, T. Gilman Kuric (Osijek, Croatia)

    Objective: The aim of this study was to determine the prevalence of malnutrition and to analyze influence of age, sex, disease duration and motor symptoms…
  • 2017 International Congress

    Treatment associated improvement in motor scores is not reflected in improvement in hand dexterity in Parkinson’s disease patients

    S. Filipović, A. Kačar (Beograd, Serbia)

    Objective: To check whether there is a correlation between measures of hand dexterity and standard motor scores in Parkinson’s diseases (PD). Even more importantly, whether…
  • 2017 International Congress

    A global survey of the use and linguistic translation of the NMSQuest and NMSScale: implications for non-motor studies in Parkinson’s disease

    A. Sauerbier, L. Klingelhoefer, R. Banerjee, S. Diaconu, R. Erro, T. Farombi, S. Gangadharan, A. Macerollo, L. Chahine, O. Jitkritsadakul, R. Biundo, M. Grilo, H. Dafsari, G. Pagano, F. Niccolini, N. Titova (London, United Kingdom)

    Objective: To collect details of linguistic validations and translations of the non-motor symptoms questionnaire (NMSQuest) and non-motor symptoms scale (NMSScale) globally.  Background: The patient completed…
  • 2017 International Congress

    Development and validation of diagnostic criteria for advanced Parkinson disease: the CDEPA questionnaire

    M.-R. Luquin, J. Kulisevsky, P. Martinez-Martin, P. Mir, E. Tolosa, P. Garcia-Delgado (Pamplona, Spain)

    Objective: Using the Delphi methodology we previously obtained a consensus on the definition and clinical characteristics of advanced Parkinson’s disease (APD). We aimed to develop…
  • 2017 International Congress

    Association of Metabolic Syndrome and Change in Unified Parkinson Disease Rating Scale Scores

    M. Leehey, S. Luo, S. Sharma, A.-M. Wills, J. Bainbridge, D. Simon, J. Schneider, Y. Zhang, A. Pérez, R. Dhall, C. Christine, C. Singer, F. Cambi (Aurora, CO, USA)

    Objective: To explore the association between metabolic syndrome and Unified Parkinson Disease Rating Scale (UPDRS) scores.  Background: While studies suggest that metabolic syndrome increases the…
  • 2017 International Congress

    Segregation of subjective and objective clinical measures in Parkinson’s disease

    K. Markopoulou, R. Frigerio, A. Premkumar, B. Schoneburg, M. Dudek, S. Walters, C. Wang, D. Maraganore (Evanston, IL, USA)

    Objective: Use standardized measures to characterize disease severity, progression, and outcomes in Parkinson’s disease (PD). Background: Subjective and objective standardized measures are usually performed in…
  • 2017 International Congress

    Development of a Paroxysmal Movement Disorder Diary for Patients with Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

    R. Hall, S. Kilgariff, P. Collins, M. Brandabur, R. Arbuckle, A. Bowden (Macclesfield, United Kingdom)

    Objective: To perform qualitative research to develop and establish content validity of a new clinical outcome assessment (COA) instrument for paroxysmal movement disorders in Glut1…
  • 2017 International Congress

    Item Response Theory Analysis of the MDS-UPDRS Items

    G. Stebbins, C. Goetz, Y. Liu, S. Luo (Chicago, IL, USA)

    Objective: To investigate the measurement characteristics of the MDS-UPDRS using item response theory (IRT) approaches. Background: The MDS-UPDRS has become the most frequently used assessment…
  • 2017 International Congress

    Assessments of Movement Disorder Symptoms and Functional Impacts in Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

    A. Bowden, S. Blair, K. Wesdock, M. Haller, M. Brandabur, P. Collins, A. Skrinar, J. Mayhew (Novato, CA, USA)

    Objective: To identify Clinical Outcome Assessments (COAs) appropriate for the evaluation of paroxysmal movement disorder symptoms and functional impact in Glut1 DS. Background: Glut1 DS…
  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley